Nuevos fármacos en el tratamiento de la incontinencia urinaria

Several classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI). Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medicat...

Descripción completa

Detalles Bibliográficos
Autores: Robles-Garcia, J.E. (José Enrique)|||/items/4f4814a5-989f-43a9-be7c-2acc111a0de4, Zudaire-Bergera, J.J. (Juan Javier)|||/items/ccce29a9-6006-4b07-bbed-4ab31d7bb91d, Rosell, D. (David)|||/items/4885ace6-0f1d-4ebf-b1cc-1ab79f2ea368, Berian-Polo, J.M. (José María)|||/items/51d32b92-0199-45f0-b6c9-2fa2afc61d22
Tipo de recurso: artículo
Fecha de publicación:2005
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:español
OAI Identifier:oai:dadun.unav.edu:10171/35415
Acceso en línea:https://hdl.handle.net/10171/35415
Access Level:acceso abierto
Palabra clave:Incontinencia urinaria de esfuerzo
Duloxetina
Vejiga hiperactiva
Solifenacina
id ES_a88f271209e532d68c93df7f9b1e0d45
oai_identifier_str oai:dadun.unav.edu:10171/35415
network_acronym_str ES
network_name_str España
repository_id_str
spelling Nuevos fármacos en el tratamiento de la incontinencia urinariaRobles-Garcia, J.E. (José Enrique)|||/items/4f4814a5-989f-43a9-be7c-2acc111a0de4Zudaire-Bergera, J.J. (Juan Javier)|||/items/ccce29a9-6006-4b07-bbed-4ab31d7bb91dRosell, D. (David)|||/items/4885ace6-0f1d-4ebf-b1cc-1ab79f2ea368Berian-Polo, J.M. (José María)|||/items/51d32b92-0199-45f0-b6c9-2fa2afc61d22Incontinencia urinaria de esfuerzoDuloxetinaVejiga hiperactivaSolifenacinaSeveral classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI). Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medication, Duloxetine, which appears to be clinically safe and effective for the treatment of SUI. On the other hand, a new muscarinic receptor antagonist, Solifenacin, has been shown in clinical trials to be clinically effective, safe and well tolerated for treating OABEdiciones Universidad de NavarraDadun. Depósito Académico Digital Universidad de Navarra20142014-03-1020052005-01-0120052005-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/35415reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraEspañolspaopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/354152026-06-21T12:47:57Z
dc.title.none.fl_str_mv Nuevos fármacos en el tratamiento de la incontinencia urinaria
title Nuevos fármacos en el tratamiento de la incontinencia urinaria
spellingShingle Nuevos fármacos en el tratamiento de la incontinencia urinaria
Robles-Garcia, J.E. (José Enrique)|||/items/4f4814a5-989f-43a9-be7c-2acc111a0de4
Incontinencia urinaria de esfuerzo
Duloxetina
Vejiga hiperactiva
Solifenacina
title_short Nuevos fármacos en el tratamiento de la incontinencia urinaria
title_full Nuevos fármacos en el tratamiento de la incontinencia urinaria
title_fullStr Nuevos fármacos en el tratamiento de la incontinencia urinaria
title_full_unstemmed Nuevos fármacos en el tratamiento de la incontinencia urinaria
title_sort Nuevos fármacos en el tratamiento de la incontinencia urinaria
dc.creator.none.fl_str_mv Robles-Garcia, J.E. (José Enrique)|||/items/4f4814a5-989f-43a9-be7c-2acc111a0de4
Zudaire-Bergera, J.J. (Juan Javier)|||/items/ccce29a9-6006-4b07-bbed-4ab31d7bb91d
Rosell, D. (David)|||/items/4885ace6-0f1d-4ebf-b1cc-1ab79f2ea368
Berian-Polo, J.M. (José María)|||/items/51d32b92-0199-45f0-b6c9-2fa2afc61d22
author Robles-Garcia, J.E. (José Enrique)|||/items/4f4814a5-989f-43a9-be7c-2acc111a0de4
author_facet Robles-Garcia, J.E. (José Enrique)|||/items/4f4814a5-989f-43a9-be7c-2acc111a0de4
Zudaire-Bergera, J.J. (Juan Javier)|||/items/ccce29a9-6006-4b07-bbed-4ab31d7bb91d
Rosell, D. (David)|||/items/4885ace6-0f1d-4ebf-b1cc-1ab79f2ea368
Berian-Polo, J.M. (José María)|||/items/51d32b92-0199-45f0-b6c9-2fa2afc61d22
author_role author
author2 Zudaire-Bergera, J.J. (Juan Javier)|||/items/ccce29a9-6006-4b07-bbed-4ab31d7bb91d
Rosell, D. (David)|||/items/4885ace6-0f1d-4ebf-b1cc-1ab79f2ea368
Berian-Polo, J.M. (José María)|||/items/51d32b92-0199-45f0-b6c9-2fa2afc61d22
author2_role author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Incontinencia urinaria de esfuerzo
Duloxetina
Vejiga hiperactiva
Solifenacina
topic Incontinencia urinaria de esfuerzo
Duloxetina
Vejiga hiperactiva
Solifenacina
description Several classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI). Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medication, Duloxetine, which appears to be clinically safe and effective for the treatment of SUI. On the other hand, a new muscarinic receptor antagonist, Solifenacin, has been shown in clinical trials to be clinically effective, safe and well tolerated for treating OAB
publishDate 2005
dc.date.none.fl_str_mv 2005
2005-01-01
2005
2005-01-01
2014
2014-03-10
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/35415
url https://hdl.handle.net/10171/35415
dc.language.none.fl_str_mv Español
spa
language_invalid_str_mv Español
language spa
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ediciones Universidad de Navarra
publisher.none.fl_str_mv Ediciones Universidad de Navarra
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869415908793909248
score 15,223283

Similares en LA Referencia